12:00 AM
Apr 27, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Aeterna Zentaris preclinical data

In a mouse xenograft model, AEZS-126 showed antitumor activity at 30 mg/kg daily. Oral bioavailability was...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >